Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

Neutrophil cathepsin G and risk of cardiovascular events in patients with diabetes mellitus

Graphical Abstract Sample Work

Type 2 diabetes mellitus (T2DM) has many complications associated with increased risk of atherosclerosis and cardiovascular events (CVEs), including increased platelet activity and inflammation. Cathepsin G (CatG) is a prothrombotic proteolytic enzyme released by neutrophils, which could act as a possible mediator in this process by stimulating the aggregation of platelets. To date, there have been no studies looking specifically at the relationship between CatG levels and the development of CVEs; therefore, the goal of this study is to determine if circulating levels of CatG can independently predict the future occurrence of CVEs among patients with T2DM.

Biomarker, mechanism and outcome in one quadrant layout

This graphical abstract summarises a study asking whether circulating neutrophil cathepsin G (CatG) predicts cardiovascular events in patients with type 2 diabetes mellitus (T2DM). The canvas is organised under three boxed headings: "Biomarkers" and "Mechanism" on the left, and "Clinical outcomes" on the right. The left side explains why CatG might matter; the right side shows how strongly it was associated with each outcome. Readers in cardiology, diabetology and thrombosis research can see the hypothesis and the evidence side by side.

Why a neutrophil enzyme could raise cardiovascular risk in diabetes

People with T2DM have a higher risk of atherosclerosis and cardiovascular events (CVEs), driven in part by increased platelet activity and chronic inflammation. Neutrophils, the most abundant white blood cells, release proteolytic enzymes when activated. CatG is one of these enzymes and has prothrombotic properties: it can stimulate platelet aggregation, providing a plausible link between inflammation and clot formation.

Before this study, no research had specifically examined whether CatG levels predict the future occurrence of CVEs. The study therefore set out to determine whether circulating CatG independently predicts cardiovascular events in patients with T2DM, which would make it a candidate marker for risk stratification and a possible target for further mechanistic work.

The left side: from biomarker to thrombus

The "Biomarkers" box shows CatG, drawn as a pair of purple hexagons, linked by a downward arrow to soluble P-selectin (sP-selectin), drawn as a teal crescent. Triple upward arrows beside both indicate that levels were raised. P-selectin is an adhesion molecule expressed on activated platelets and endothelium, and its soluble form is widely used as a marker of platelet activation, so this pairing ties CatG to the platelet pathway in a single step.

The "Mechanism" box expands that step into a cycle. A neutrophil releases CatG; CatG molecules drive thrombus formation, drawn as red cells caught in a fibrin mesh; and the thrombus releases sP-selectin. Curved arrows give the sequence a clockwise reading order. The same hexagon and crescent shapes are reused from the Biomarkers box, so readers do not need a legend to connect the two parts. Using shape rather than colour alone to identify each molecule also keeps the figure readable for people with colour vision deficiency. Note that the source graphic labels the marker "sP-Selection"; the correct term is P-selectin, a detail worth checking in any adaptation.

The right side: a forest plot of adjusted hazard ratios

Below three outcome icons (a heart, a brain and a blood vessel), the right half presents a forest plot with adjusted hazard ratios (aHR) on a horizontal axis running from 2.5 to 20, and a dotted reference line near 1:

OutcomeaHRP value
Non-fatal coronary events8.47<0.001
Cerebrovascular events3.900.011
Cardiovascular death5.82<0.001
All-cause death3.83<0.001
Composite outcome6.08<0.001

Each point has horizontal bars showing its confidence interval. The interval for non-fatal coronary events is the widest, extending close to the right edge of the axis, while the interval for all-cause death is the narrowest. A forest plot conveys this precision information far better than a list of numbers, and it lets readers see that every interval lies to the right of the reference line.

Interpreting adjusted hazard ratios responsibly

An adjusted hazard ratio estimates the association between CatG and the rate of an event after accounting for other variables in the model, such as established risk factors. Large values like those shown suggest a strong association, but wide intervals indicate uncertainty about the exact magnitude, often because the number of events was limited. As an observational cohort analysis, the study would be reported against STROBE, and the figure appropriately describes CatG as associated with, rather than causing, cardiovascular events. The mechanism box is a hypothesis drawn from existing biology, not a result measured in patients.

This page is a writing and design sample and is not intended as clinical guidance.

Applying this split design to your own biomarker study

The left-mechanism, right-outcomes structure suits any prognostic biomarker study with a credible biological rationale. Keep shapes consistent between the biomarker and mechanism areas, and use a forest plot when there are several outcomes. Pubrica's graphical abstract service designs figures of this kind, and analyses such as multivariable Cox regression can be reviewed through biostatistics support before submission.

Questions about this sample

What is soluble P-selectin and why is it paired with cathepsin G?

Soluble P-selectin is a circulating form of an adhesion molecule found on activated platelets and endothelium and is used as a marker of platelet activation. Pairing it with cathepsin G in the figure links the neutrophil enzyme to the platelet pathway, supporting the idea that cathepsin G could increase cardiovascular risk by promoting thrombosis.

Which outcome showed the largest adjusted hazard ratio?

Non-fatal coronary events had the largest adjusted hazard ratio, 8.47, with P < 0.001. Its confidence interval is also the widest in the forest plot, which indicates that the true size of the association is uncertain, even though it clearly lies above the reference line.

Does the mechanism panel show what was measured in patients?

No. The cycle of neutrophil activation, cathepsin G release, thrombus formation and soluble P-selectin release illustrates the biological rationale for the study. The measured results are the biomarker levels and the adjusted hazard ratios shown on the right side of the figure.

pubrica services with experts

Research your Services with our experts

Delivered on-time or your money back

Give yourself the academic edge today

Each order includes

  • On-time delivery or your money back
  • A fully qualified writer in your subject
  • In-depth proofreading by our Quality Control Team
  • 100% confidentiality, the work is never re-sold or published
  • Standard 7-day amendment period
  • A paper written to the standard ordered
  • A detailed plagiarism report
  • A comprehensive quality report

Enquire Now

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.